BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/8/2017 3:24:00 PM | Browse: 380 | Download: 211
Publication Name World Journal of Clinical Oncology
Manuscript ID 29095
Country/Territory United States
2016-07-28 13:49
Peer-Review Started
2016-07-30 18:08
To Make the First Decision
2016-09-02 14:26
Return for Revision
2016-09-08 10:37
2016-09-20 11:49
Second Decision
2016-12-14 18:43
Accepted by Journal Editor-in-Chief
2016-12-15 00:07
Accepted by Company Editor-in-Chief
2016-12-28 15:31
Articles in Press
2016-12-28 15:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-01-17 16:51
Publish the Manuscript Online
2017-02-08 15:32
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Therapeutic management options for stage III non-small cell lung cancer
Manuscript Source Invited Manuscript
All Author List Stephanie M Yoon, Talha Shaikh and Mark Hallman
Funding Agency and Grant Number
Corresponding author Talha Shaikh, MD, Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, United States. talha.shaikh@fccc.edu
Keywords Non-small cell lung cancer; Chemo­radiotherapy; Multi-modality; Targeted therapy; Dose-escalation
Core Tip Locally advanced non-small cell lung cancer consists of a heterogeneous population making manage-ment challenging. Multiple strategies are being deve-loped to maximize survival and disease control. The role of surgery is being re-evaluated given new insight into the efficacy chemotherapy and radiation. Multi-modality therapy is playing an increasingly important role for both resectable and unresectable stage III patients. Chemoradiation plays a large role in the management of inoperable or unresectable patients. Third generation chemotherapy and other targeted therapies are being incorporated into chemoradiation. Radiation dose-escalation, alternative fractionation schedules, intensity-modulated radiotherapy, and proton therapy are evaluated to improve outcomes from chemoradiation.
Publish Date 2017-02-08 15:32
Citation Yoon SM, Shaikh T, Hallman M. Therapeutic management options for stage III non-small cell lung cancer. World J Clin Oncol 2017; 8(1): 1-20
Url http://www.wjgnet.com/2218-4333/full/v8/i1/1.htm
DOI http://dx.doi.org/10.5306/wjco.v8.i1.1
Full Article (PDF) WJCO-8-1.pdf
Full Article (Word) WJCO-8-1.doc
Manuscript File 29095-Review.docx
Answering Reviewers 29095-Answering reviewers.pdf
Audio Core Tip 29095-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 29095-Conflict-of-interest statement.pdf
Copyright License Agreement 29095-Copyright assignment.pdf
Peer-review Report 29095-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 29095-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 29095-Scientific misconduct check.pdf
Scientific Editor Work List 29095-Scientific editor work list.pdf